Leukemia
📧 Sign up to get email alerts when something new happens for Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-04-05Clinical Trial Update: Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors [NA]
The clinical trial update notes completion of a cognitive-behavioral intervention designed to help cancer survivors manage worry, uncertaint…
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous Therapy [Phase 1]
This Phase 1 trial update reports on transplantation using specially treated bone marrow for hematologic cancers that have not responded to …
-
CLINICAL_TRIALS trial_result · 2017-03-24Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant [Phase 2]
Phase 2 trial evaluating donor stem cell transplantation for patients with relapsed hematologic malignancies or secondary myelodysplasia who…
-
CLINICAL_TRIALS trial_result · 2017-03-22Clinical Trial Update: Bendamustine Hydrochloride, Clofarabine, and Etoposide in Treating Younger Patients With Relapsed or Refractory Hematologic Malignancies [Phase 1]
A Phase 1 trial investigates a three-drug combination (bendamustine, clofarabine, and etoposide) in younger patients with relapsed or refrac…
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Phase 2 Dasatinib Combo With Smoothened (SMO) Antagonist (BMS-833923) [Phase 2]
A Phase 2 trial of dasatinib in combination with the SMO antagonist BMS-833923 for leukemia was terminated, with results posted in 2017.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: Trial of Allogeneic Stem Cell Transplants From HLA Compatible, Related and Unrelated Donors After a Myeloablative Preparative Regimen With Hyperfractionated TBI, Thiotepa and Fludarabine For Adult Patients With Lymphohematopoietic Disorders [Phase 2]
Phase 2 trial evaluating myeloablative conditioning with hyperfractionated total body irradiation plus thiotepa and fludarabine followed by …
-
CLINICAL_TRIALS trial_result · 2017-03-08Clinical Trial Update: Yoga to Alleviate Fatigue, Anxiety and Pain in Adolescents During Treatment for Lymphoma or Leukemia [NA]
A pediatric oncology trial evaluated yoga to alleviate fatigue, anxiety, and pain in adolescents undergoing treatment for leukemia or lympho…
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: Reduced Intensity Transplant Using Extracorporeal Photopheresis [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase 1/2 study evaluating reduced-intensity transplant using extracorporeal photophe…
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy [Phase 2]
Phase 2 trial evaluating epoetin alfa or darbepoetin alfa for chemotherapy-induced anemia; results from a completed study were posted in 201…
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: AMG 319 Lymphoid Malignancy FIH [Phase 1]
First-in-human Phase 1 clinical trial update for AMG 319 in lymphoid malignancies, including chronic lymphocytic leukemia and various lympho…
-
CLINICAL_TRIALS trial_result · 2017-02-07Clinical Trial Update: Pilot Lenalidomide in Adult Diamond-Blackfan Anemia Patients w/ RBC Transfusion-Dependent Anemia [Phase 1]
Phase 1 pilot trial of lenalidomide in adult Diamond-Blackfan anemia patients with transfusion-dependent anemia. The study was terminated an…
-
CLINICAL_TRIALS trial_result · 2017-02-03Clinical Trial Update: Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome [NA]
This clinical trial update indicates the Lactobacillus probiotic study intended to prevent infection in patients undergoing donor stem cell …
-
CLINICAL_TRIALS trial_result · 2017-01-26Clinical Trial Update: Allogeneic Transplantation From Related Haploidentical Donors [Phase 2]
A Phase 2 clinical trial evaluating allogeneic transplantation from related haploidentical donors for blood cancers and leukemia has complet…
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: Post-transplant Autologous Cytokine-induced Killer (CIK) Cells for Treatment of High Risk Hematologic Malignancies [Phase 1]
Phase 1 trial evaluating post-transplant autologous cytokine-induced killer (CIK) cells in high-risk hematologic malignancies has been compl…
-
CLINICAL_TRIALS trial_result · 2016-12-20Clinical Trial Update: "LANK-2": Activated and Expanded NK Cell Immunotherapy Together With Salvage Chemotherapy in Children, Adolescents and Young Adults With Relapsed or Refractary Acute Leukemia [Phase 2]
Phase 2 trial evaluating LANK-2 NK cell immunotherapy with salvage chemotherapy in children, adolescents, and young adults with relapsed or …
-
CLINICAL_TRIALS trial_result · 2016-12-15Clinical Trial Update: Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer [Phase 1]
Phase 1 study evaluating alemtuzumab with combination chemotherapy followed by donor lymphocyte infusion in patients undergoing donor stem c…
-
CLINICAL_TRIALS trial_result · 2016-12-14Clinical Trial Update: Acceptability of Less Harmful Alternatives to Cigarettes [NA]
This completed clinical trial posted results in 2016 evaluating the acceptability of less harmful alternatives to cigarettes across multiple…
-
CLINICAL_TRIALS trial_result · 2016-12-08Clinical Trial Update: Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder [Phase 3]
Phase 3 trial evaluating cyclosporine eye drops to prevent eye graft-versus-host disease in patients after donor stem cell transplant for he…
-
CLINICAL_TRIALS trial_result · 2016-11-29Clinical Trial Update: Post-transfusion Platelet Count
A completed clinical trial update focusing on post-transfusion platelet counts in patients with leukemia and multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2016-11-23Clinical Trial Update: Exercise and Quality of Life in Leukemia Patients [NA]
A completed clinical trial evaluating the impact of an exercise program on quality of life in patients with acute leukemia.
-
CLINICAL_TRIALS trial_result · 2016-11-07Clinical Trial Update: PKC412 and 5-Azacytidine [Phase 1, Phase 2]
A phase 1/2 trial evaluating PKC412 (midostaurin) in combination with 5-azacytidine for leukemia has completed recruitment with results post…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: Assessment of the Fungal Infection Incidence Across Canada for High Risk Participants With Hematological Disease (P07501)
This completed Canadian clinical trial assessed the incidence of fungal infections among high-risk participants with hematologic disease. Re…
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: Study to Assess Safety, Tolerability and Preliminary Efficacy of BKM120, PI3K Kinase Inhibitor, With Advanced Leukemias [Phase 1]
A Phase 1 trial completed evaluating the safety, tolerability, and preliminary efficacy of BKM120 (buparlisib), a PI3K inhibitor, in patient…
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Pre-reinductive Decitabine and Vorinostat in Relapsed Lymphoblastic Lymphoma or Acute Lymphoblastic Leukemia [Phase 2]
A Phase 2 clinical trial investigating pre-reinductive decitabine and vorinostat in relapsed lymphoblastic lymphoma or acute lymphoblastic l…
-
CLINICAL_TRIALS trial_result · 2016-10-24Clinical Trial Update: Efficiency Study of Low Dose of IL-2 to Prevent Relapse in Standard Risk Leukemia After Transplantation [NA]
A clinical trial evaluating low-dose interleukin-2 to prevent relapse in standard-risk leukemia after transplantation has been terminated.